|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023866,
umls-concept:C0036525,
umls-concept:C0087111,
umls-concept:C0205099,
umls-concept:C0205171,
umls-concept:C0206630,
umls-concept:C0282443,
umls-concept:C0458083,
umls-concept:C0596545,
umls-concept:C0814225,
umls-concept:C0868928,
umls-concept:C1522484,
umls-concept:C1552617
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-5-25
|
|
pubmed:abstractText |
Endometrial stromal sarcoma (ESS) is a rare disease with probably less than 700 new cases in the US or EU per year. ESS usually expresses steroidal receptors and is regarded to be hormone-sensitive. A higher risk in women receiving estrogen replacement therapy (ERT) or tamoxifen has been suspected, and remissions following treatment with progestins have been reported in case studies. Aromatase inhibitors represent an interesting new treatment option. Due to the rarity of the tumor, only few case series and no prospective studies are published. We therefore conducted a retrospective study to evaluate the influence of hormonal treatment to ESS.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
464-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16368128-Adult,
pubmed-meshheading:16368128-Aged,
pubmed-meshheading:16368128-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16368128-Endometrial Stromal Tumors,
pubmed-meshheading:16368128-Estrogen Replacement Therapy,
pubmed-meshheading:16368128-Female,
pubmed-meshheading:16368128-Humans,
pubmed-meshheading:16368128-Medroxyprogesterone Acetate,
pubmed-meshheading:16368128-Middle Aged,
pubmed-meshheading:16368128-Nitriles,
pubmed-meshheading:16368128-Pelvic Neoplasms,
pubmed-meshheading:16368128-Peritoneal Neoplasms,
pubmed-meshheading:16368128-Retrospective Studies,
pubmed-meshheading:16368128-Tamoxifen,
pubmed-meshheading:16368128-Triazoles,
pubmed-meshheading:16368128-Uterine Neoplasms
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
|
|
pubmed:affiliation |
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, HELIOS-Klinikum Berlin-Buch, Robert-Rössle-Klink, Charité Campus Buch, Lindenberger Weg 80, D-13125 Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article
|
